# Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

> **NCT03170999** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 199 (actual)

## Conditions studied

- Airway Obstruction

## Interventions

- **OTHER:** Focus group interview
- **OTHER:** Draft item set
- **OTHER:** Candidate item set

## Key facts

- **NCT ID:** NCT03170999
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-29
- **Primary completion:** 2020-05-29
- **Final completion:** 2020-05-29
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170999, "Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03170999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*